| Literature DB >> 34857760 |
Matthieu Lacroix1,2, Laetitia K Linares1,2, Natalia Rueda-Rincon3, Katarzyna Bloch3, Michela Di Michele1,2, Carlo De Blasio1,2, Caroline Fau1,2, Laurie Gayte1,2, Emilie Blanchet1, Aline Mairal4, Rita Derua5, Fernando Cardona6, Diane Beuzelin4, Jean-Sebastien Annicotte7, Nelly Pirot1,8, Adeline Torro1, Francisco J Tinahones9, Florence Bernex1,8, Justine Bertrand-Michel4, Dominique Langin4,10, Lluis Fajas11, Johannes V Swinnen3, Laurent Le Cam12,13.
Abstract
Growing evidence supports the importance of the p53 tumor suppressor in metabolism but the mechanisms underlying p53-mediated control of metabolism remain poorly understood. Here, we identify the multifunctional E4F1 protein as a key regulator of p53 metabolic functions in adipocytes. While E4F1 expression is upregulated during obesity, E4f1 inactivation in mouse adipose tissue results in a lean phenotype associated with insulin resistance and protection against induced obesity. Adipocytes lacking E4F1 activate a p53-dependent transcriptional program involved in lipid metabolism. The direct interaction between E4F1 and p53 and their co-recruitment to the Steaoryl-CoA Desaturase-1 locus play an important role to regulate monounsaturated fatty acids synthesis in adipocytes. Consistent with the role of this E4F1-p53-Steaoryl-CoA Desaturase-1 axis in adipocytes, p53 inactivation or diet complementation with oleate partly restore adiposity and improve insulin sensitivity in E4F1-deficient mice. Altogether, our findings identify a crosstalk between E4F1 and p53 in the control of lipid metabolism in adipocytes that is relevant to obesity and insulin resistance.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34857760 PMCID: PMC8639890 DOI: 10.1038/s41467-021-27307-3
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919